Gilmore Neil O'Neill - CEO, Director at Editas Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Gilmore Neil O'Neill - trading volume in the past year for Editas Medicine, Inc.

Holdings reported by Gilmore Neil O'Neill for Editas Medicine, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 315,279 $1.73 M $5.50 Jun 4, 2024 Direct
Stock Option (right to buy) 392,100 Mar 2, 2024 Direct Common Stock

Transactions reported by Gilmore Neil O'Neill for Editas Medicine, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership